bioMerieux stock forecast
Want to see FR:BIM full AI Analyst Report?
bioMerieux (BIM) Stock Forecast & Price Target
BIM Analyst Ratings
BIM Stock 12 Month Forecast
Average Price Target
€89.00▼(-3.47% Downside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Pablo de Renteria | Kepler Capital | €95 | hold | 3.04%Upside | Downgraded | 11/05/26 | ||
| David Westenberg | Piper Sandler | €80→€100 | hold | 8.46%Upside | Reiterated | 11/04/26 | ||
| Anchal Verma | J.P. Morgan | €71.60→€84 | hold | -8.89%Downside | Reiterated | 11/04/26 | ||
| Charles Pitman CFA | Barclays | €80→€90 | hold | -2.39%Downside | Reiterated | 11/03/26 | ||
| Jan Koch | Deutsche Bank | €75→€103 | buy | 11.71%Upside | Upgraded | 10/28/26 | ||
| Natalia Webster | RBC Capital | €85 | hold | -7.81%Downside | Reiterated | 10/23/26 | ||
| Aisyah Noor | Morgan Stanley | €64→€66 | sell | -28.42%Downside | Reiterated | 09/11/26 | ||
| Kavya Deshpande | UBS | €80→€78 | hold | -15.40%Downside | Reiterated | 07/29/26 | ||
| Hugo Solvet | Exane BNP Paribas | €100 | hold | 8.46%Upside | Downgraded | 01/28/26 | ||
| Anna Ractliffe | Bank of America Securities | €90→€115 | hold | 24.73%Upside | Upgraded | 12/12/25 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Pablo de RenteriaKepler Capital | HoldDowngraded€95 | 11/05/26 | 3.04%Upside | ||
| David WestenbergPiper Sandler | HoldReiterated€80→€100 | 11/04/26 | 8.46%Upside | ||
| Anchal VermaJ.P. Morgan | HoldReiterated€71.60→€84 | 11/04/26 | -8.89%Downside | ||
| Charles Pitman CFABarclays | HoldReiterated€80→€90 | 11/03/26 | -2.39%Downside | ||
| Jan KochDeutsche Bank | BuyUpgraded€75→€103 | 10/28/26 | 11.71%Upside | ||
| Natalia WebsterRBC Capital | HoldReiterated€85 | 10/23/26 | -7.81%Downside | ||
| Aisyah NoorMorgan Stanley | SellReiterated€64→€66 | 09/11/26 | -28.42%Downside | ||
| Kavya DeshpandeUBS | HoldReiterated€80→€78 | 07/29/26 | -15.40%Downside | ||
| Hugo SolvetExane BNP Paribas | HoldDowngraded€100 | 01/28/26 | 8.46%Upside | ||
| Anna RactliffeBank of America Securities | HoldUpgraded€90→€115 | 12/12/25 | 24.73%Upside |
Best Analysts Covering bioMerieux
Copying Jan Koch's trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of -1.80% per trade.
Copying Jan Koch's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of -0.84% per trade.
Copying Aisyah Noor's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -23.43% per trade.
BIM Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 0 | 1 | 1 |
| Hold | 9 | 9 | 5 | 2 | 6 |
| Sell | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 12 | 11 | 6 | 4 | 8 |
In the current month, BIM has received 1 Buy Ratings, 6 Hold Ratings, and 1 Sell Ratings. BIM average Analyst price target in the past 3 months is 89.00.
BIM Financial Forecast
BIM Earnings Forecast
Next quarter’s earnings estimate for BIM is EUR 2.52 with a range of EUR 2.29 to EUR 2.74. The previous quarter’s EPS was EUR 1.99. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
BIM Sales Forecast
Next quarter’s sales forecast for BIM is EUR 1.17B with a range of EUR 1.16B to EUR 1.19B. The previous quarter’s sales results were EUR 1.96B. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.
